Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Bendazol
Cat. No.:
0225LY-1158
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Bendazol is a pharmaceutical compound primarily indicated for the management of cerebral angiospasm and hypertension.
Synonym:
Dibazol; Dibazole; 621-72-7; 2-Benzylbenzimidazole; 2-Benzyl-1H-benzimidazole; 2-Benzyl-1H-benzoimidazole; Dibazol; 2-Benzyl-1H-benzo[d]imidazole; Dibazole; Bendazole; Tromasedan; Dibasol; 2-Benzylbenziminazole; Bendazolo; Bendazolum; 1H-Benzimidazole, 2-(phenylmethyl)-; 2-(Phenylmethyl)-1H-benzimidazole; 2-Benzyl-1H-1,3-Benzodiazole
CAS No.:
621-72-7
Compound CID:
12132
Formula:
C14H12N2
Formula Weight:
208.26
Specification
Relative Density:
1.193 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Bendazol can be used in vascular research or play a role in studying its immunomodulatory and hypotensive effects.
Library Information
Target:
Dopamine receptor; NO synthase
Receptor:
Dopamine; NO synthase
Pathways:
Immunology/Inflammation; GPCR/G protein signaling; Neuronal signaling
Plate Number:
AOCL-15
Plate Location:
h5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
55 mg/mL; 264.09 mM
